This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is likely to reduce the impact of a monopsony? a. Absence of competing firms ... (Read 41 times)

joblessjake

  • Hero Member
  • *****
  • Posts: 555
Which of the following is likely to reduce the impact of a monopsony?
 a. Absence of competing firms
 b. Higher search costs
 c. An increased ability of workers to relocate elsewhere
  d. Higher movement and information costs

Question 2

Which of the following is a disadvantage of the U-form structure?
 a. In case of multiple products sold in different markets, a U-form structure is difficult to maintain.
  b. A U-form structure requires a larger staff to evaluate top-level decision making than other organization structures.
  c. A U-form structure necessitates a multiple-level decision-making process.
  d. The amount of information that is considered for decision-making in a U-form structure is less than other structures.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wilsonbho

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

c

Answer to Question 2

A




joblessjake

  • Member
  • Posts: 555
Reply 2 on: Jun 30, 2018
Great answer, keep it coming :)


AngeliqueG

  • Member
  • Posts: 343
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library